Back to Woodline Partners LP Woodline Partners LP

EPRXEPRX
2 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in EUPRAXIA PHARMACEUTICALS INC

Woodline Partners LP holds 746,864 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $4.9M as of 2026-Q2. The position was increased (+69.5% shares). EPRX represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$4.9M

Current Shares

746,864

Total Value Change

+$1.7M

Total Shares Change

+306,313

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
746,864
+69.5%
$4.9M0.0%$6.61
40
2026-Q1
New
440,551
-
$3.2M0.0%$8.02
37

Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used